Table 2.

Analysis of PAQR3^a and VEGF-A^b positive expression and related factors

Variable	n	PAQR3 expression		P Value	VEGF-A expression		P Value
		Negative (-)	Positive (+)		Negative (-)	Positive (+)
Age (year)
≥60	48	28 (58.3)	20 (41.7)	0.650	14 (29.2)	34 (70.8)	0.722
<60	38	24 (63.2)	14 (36.8)		13 (34.2)	25 (65.8)
Sex
Male	32	16 (50.0)	16 (50.0)	0.127	8 (25.0)	24 (75.0)	0.325
Female	54	36 (66.7)	18 (33.3)		19 (35.2)	35 (64.8)
Tumor size (cm)
<3	35	25 (71.4)	10 (28.6)	0.085	12 (34.3)	23 (65.7)	0.632
≥3	51	27 (52.9)	24 (47.1)		15 (29.4)	36 (70.6)
TNM stage
I-II	39	18 (46.2)	21 (53.8)	0.013	17 (43.6)	22 (56.4)	0.026
III-IV	47	34 (72.3)	13 (27.7)		10 (21.3)	37 (78.7)
Differentiation
Well + moderate	56	29 (51.8)	27 (48.2)	0.025	25 (44.6)	31 (55.4)	0.001
Poor	30	23 (76.7)	7 (23.3)		2 (6.7)	28 (93.3)
Lymphatic metastasis
no	41	20 (48.8)	21 (51.2)	0.034	21 (51.2)	20 (48.8)	0.001
yes	45	32 (71.1)	13 (28.9)		6 (13.3)	39 (86.7)

^aProgesterone and adipoQ receptor family member 3 (PAQR3);

^bVascular endothelial growth factor)-A.